period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.85,0.35,0.0,0.2916666666666667,[1],FDA is aware of emerging supply issues with a manufacturer. We encourage all stakeholders to report any related disruptions and to ensure continued patient access. Coordination with the industry will continue as needed.
1,1.5,0.85,0.65,0.0,0.43333333333333335,[1],The FDA is closely monitoring the emerging shortage of the specified medication and encourages manufacturers to voluntarily report production quantities and any disruption issues. We are committed to facilitating effective coordination to address potential supply gaps.
2,1.3,1.05,0.25,0.050000000000000044,0.1923076923076923,[1],The FDA is aware of an emerging shortage of a critical medication. We encourage manufacturers to increase transparency and collaboration to address supply disruptions efficiently. Stakeholders should avoid unnecessary stockpiling to ensure equitable distribution.
3,1.2,1.1783333333333332,0.021666666666666723,0.17833333333333323,0.018055555555555602,[1],The FDA is closely monitoring an emerging shortage situation. We encourage stakeholders to report any supply disruptions and are prepared to coordinate if needed.
